Immunome: Pay

Immunome paid its 3 named executives $21.5M in total in FY2024 (Dec). CEO Clay Siegall, Ph.D. was paid $9.2M of that.

Pay$100 in the stock at the end of FY22 → $481

CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Clay Siegall, Ph.D.President, Chief Executive Officer and Chairman of the Board


FY2024 (Dec)
FY2023 (Dec)

2 years

Robert Lechleider, M.D.Chief Medical Officer


FY2023 (Dec)

1 year

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.